Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

LY303366 is a novel semisynthetic derivative of echinocandin B and a potent inhibitor of fungal (1,3)-β-d-glucan synthase. The antifungal efficacy and safety of LY303366 were investigated in treatment and prophylaxis of primary pulmonary aspergillosis due to Aspergillus fumigatus in persistently neu...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Petraitis, Vidmantas, Petraitiene, Ruta, Groll, Andreas H., Bell, Aaron, Callender, Diana P., Sein, Tin, Schaufele, Robert L., McMillian, Carl L., Bacher, John, Walsh, Thomas J.
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1998
Assuntos:	Experimental Therapeutics
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105963/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9797223/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.11.2898
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!